ABNORMAL TCR V-BETA REPERTOIRE IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA

被引:20
作者
COLEMAN, S [1 ]
PERERA, P [1 ]
FISHER, J [1 ]
HOY, T [1 ]
BURNETT, AK [1 ]
LIM, SH [1 ]
机构
[1] UNIV WALES COLL MED,DEPT HAEMATOL,CARDIFF CF4 4XN,S GLAM,WALES
关键词
CML; TCR V-BETA REPERTOIRE; DELETION;
D O I
10.1111/j.1365-2141.1995.tb05159.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have used 25 sets of oligonucleotide primers specific for the 24 known major human T-cell receptor (TCR) V beta families in polymerase chain reactions to analyse the T-cell repertoire of the peripheral blood in seven patients with chronic myeloid leukaemia (CML). In contrast to normal healthy individuals, all seven patients exhibited variable degrees of TCR V beta specific T-cell,deletion, ranging from two to eight of the 24 major families. T cells bearing V beta 17 and 8 were most commonly deleted. These results suggest a superantigen effect associated with CML, The patterns of deletion did not appear to correlate with either of the two bcr-abl transcripts. The reason and aetiological agent responsible for the T-cell deletion remain speculative. Further work is ongoing to characterize this phenomenon in animal models and patients with CML.
引用
收藏
页码:358 / 363
页数:6
相关论文
共 22 条
[1]  
CAIGNARD A, 1994, CANCER RES, V54, P1292
[2]   INTERACTION OF STAPHYLOCOCCUS-AUREUS TOXIN SUPERANTIGENS WITH HUMAN T-CELLS [J].
CHOI, YW ;
KOTZIN, B ;
HERRON, L ;
CALLAHAN, J ;
MARRACK, P ;
KAPPLER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8941-8945
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]   T-CELL ANTIGEN RECEPTOR GENES AND T-CELL RECOGNITION [J].
DAVIS, MM ;
BJORKMAN, PJ .
NATURE, 1988, 334 (6181) :395-402
[5]   GENERATION OF LEUKEMIA-REACTIVE CYTOTOXIC LYMPHOCYTE-T CLONES FROM THE HLA-IDENTICAL BONE-MARROW DONOR OF A PATIENT WITH LEUKEMIA [J].
FABER, LM ;
VANLUXEMBURGHEIJS, SAP ;
WILLEMZE, R ;
FALKENBURG, JHF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1283-1289
[6]  
FERRADINI L, 1992, CANCER RES, V52, P4649
[7]  
HALE G, 1994, BONE MARROW TRANSPL, V13, P597
[8]   T-CELL TOLERANCE BY CLONAL ELIMINATION IN THE THYMUS [J].
KAPPLER, JW ;
ROEHM, N ;
MARRACK, P .
CELL, 1987, 49 (02) :273-280
[9]   DONOR LEUKOCYTE TRANSFUSIONS FOR TREATMENT OF RECURRENT CHRONIC MYELOGENOUS LEUKEMIA IN MARROW TRANSPLANT PATIENTS [J].
KOLB, HJ ;
MITTERMULLER, J ;
CLEMM, C ;
HOLLER, E ;
LEDDEROSE, G ;
BREHM, G ;
HEIM, M ;
WILMANNS, W .
BLOOD, 1990, 76 (12) :2462-2465
[10]   RECURRENCE OF PH'-POSITIVE LEUKEMIA IN DONOR CELLS AFTER MARROW TRANSPLANTATION FOR CHRONIC GRANULOCYTIC-LEUKEMIA [J].
MARMONT, A ;
FRASSONI, F ;
BACIGALUPO, A ;
PODESTA, M ;
PIAGGIO, G ;
VANLINT, MT ;
CAIMO, A ;
DEFILIPPI, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (14) :903-906